NotesFAQContact Us
Search Tips
Back to results
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ937327
Record Type: Journal
Publication Date: 2011
Pages: 9
Abstractor: As Provided
ISSN: ISSN-0040-5841
Medication Treatment for Attention Deficit Hyperactivity Disorder
Ryan, Joseph B.; Katsiyannis, Antonis; Hughes, Elizabeth M.
Theory Into Practice, v50 n1 p52-60 2011
Attention deficit hyperactivity disorder (ADHD) has become the most commonly diagnosed psychiatric disorder among school-age children. For more than half a century, physicians have prescribed medications to help manage behaviors such as hyperactivity, impulsivity, and inattention. Today, there is a growing consensus that ADHD is a biologically based disorder, and medication is now considered the first line treatment. This article discusses the therapeutic benefits and potential side effects of psychotropic medications commonly prescribed to youth with ADHD, academic and behavioral benefits associated with medication therapy, recommendations for monitoring medication efficacy, legal considerations, and the importance of establishing school medication policies. (Contains 4 tables.)
Routledge. Available from: Taylor & Francis, Ltd. 325 Chestnut Street Suite 800, Philadelphia, PA 19106. Tel: 800-354-1420; Fax: 215-625-2940; Web site:
Publication Type: Journal Articles; Reports - Descriptive
Education Level: Elementary Secondary Education
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A
Identifiers - Laws, Policies, & Programs: Family Educational Rights and Privacy Act 1974; Health Insurance Portability and Accountability Act 1996; Individuals with Disabilities Education Act